The RESONANCE Recurrent Pericarditis Patient Registry Website is now up and running! This Registry will give a voice to people living with recurrent pericarditis. The requirement is that you have…

The RESONANCE Recurrent Pericarditis Patient Registry Website is now up and running! This Registry will give a voice to people living with recurrent pericarditis. The requirement is that you have…
On March 18, 2021, Kiniksa Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA) of ARCALYST (rilonacept) for the treatment of recurrent pericarditis and reduction in risk of…